Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502297.6Aexternal-prioritypatent/GB9502297D0/en
Priority claimed from GBGB9503112.6Aexternal-prioritypatent/GB9503112D0/en
Priority claimed from GBGB9509807.5Aexternal-prioritypatent/GB9509807D0/en
Application filed by SmithKline Beecham LtdfiledCriticalSmithKline Beecham Ltd
Priority claimed from ES09600262Aexternal-prioritypatent/ES2114471B1/en
Publication of ES2149726A1publicationCriticalpatent/ES2149726A1/en
Application grantedgrantedCritical
Publication of ES2149726B1publicationCriticalpatent/ES2149726B1/en
Nuevos compuestos de paroxetina. Se describen en concreto hidrocloruro de paroxetina anhidro sustancialmente exento de propan-2-ol combinado, varias formas del anterior, procedimientos para preparar el anterior, nuevos compuestos intermedios útiles en la preparación del anterior y métodos de tratamiento y/o prevención de ciertas enfermedades por administración de los compuestos de la invención a un paciente que se encuentra en necesidad de ellos. Figura 1a.New paroxetine compounds. In particular, anhydrous paroxetine hydrochloride substantially free of combined propan-2-ol, various forms of the above, methods for preparing the above, new intermediate compounds useful in the preparation of the above and methods of treatment and / or prevention of certain diseases by administration of the compounds of the invention to a patient in need thereof. Figure 1a.
ES9900042A1995-02-061996-02-05
NEW PAROXETINE COMPOUNDS.
Expired - Fee RelatedES2149726B1
(en)
PHARMACEUTICAL COMPOSITIONS, A PROCEDURE FOR PREPARING SUCH COMPOSITIONS AND USE OF SUCH COMPOSITIONS IN THE TREATMENT OF OPHTHALMIC DISEASES AND METHODS FOR TREATING SUCH DISEASES
A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS
OMEGA-AMIDAS OF N-ARILSULFONIL-AMINO ACIDS, A PROCEDURE FOR THE PREPARATION, MEDICATION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT.